Skip to main content

Table 1 Cohort summary statistics

From: Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity

Characteristics

Mild (n = 119)

Severe (n = 116)

All (n = 235)

Cohen’s d

Longitudinal ARMSS score

Median (IQR)

1.21 (0.72, 1.86)

8.63 (7.86, 9.20)

2.86 (1.20, 8.62)

8.87

Range

0.17–3.01

6.52–9.92

0.17–9.92

Disease course at blood collection

RRMS

118 (99.2%)

46 (39.6%)

163 (69.4%)

–

SPMS

0 (0.0%)

70 (60.4%)

71 (30.6%)

Disease course at most recent visit

RRMS

117 (98.3%)

39 (33.6%)

157 (66.8%)

 

SPMS

1 (0.008%)

77 (66.4%)

78 (33.2%)

 

Sex

Female

119 (100.0%)

116 (100.0%)

235 (100.0%)

–

Male

0 (0%)

0 (0%)

0 (0%)

Age at most recent visit

Median (IQR)

53.57 (45.92, 62.14)

53.47 (45.34, 61.33)

52.41 (43.81, 59.31)

0.15

Range

29.00–76.35

28.80–76.35

28.80–76.21

Age at blood collection

Median (IQR)

49.10 (40.75, 57.62)

48.40 (40.10, 56.50)

47.80 (39.85, 55.35)

0.11

Range

24.10–72.20

24.00–73.00

24.00–73.00

Symptom duration (years)

Median (IQR)

15.90 (11.45, 20.98)

24.18 (19.65, 31.70)

19.92 (13.79, 26.49)

0.95

Range

5.85–38.11

11.91–47.13

5.85–47.13

ARR

Median (IQR)

0.10 (0.00, 0.20)

0.17 (0.00, 0.38)

0.11 (0.00, 0.26)

0.39

Range

0.00–0.82

0.00–1.08

0.00–1.08

DMT at blood collection

Yes

84 (70.5%)

68 (58.6%)

152 (64.7%)

–

No

35 (29.5%)

48 (41.4%)

83 (35.3%)

Follow-up in MSBase (years)

Median (IQR)

11.76 (10.24, 14.24)

11.27 (9.78, 13.29)

11.13 (9.49, 12.59)

0.25

Range

5.15–21.96

5.15–32.16

5.26–32.16

Number of EDSS scores assessed

Median (IQR)

15.00 (11.00, 21.25)

15.00 (11.00, 19.00)

14.00 (10.00, 18.00)

0.29

Range

3.00–47.00

3.00–47.00

3.00–34.00

  1. ARMSS age-related multiple sclerosis severity score, IQR interquartile range, EDSS expanded disability status scale, ARR annualised relapse rate, DMT disease-modifying therapy
  2. *MS course data missing for one patient